Florida Senate - 2022 COMMITTEE AMENDMENT Bill No. CS for SB 1010 Ì920488JÎ920488 LEGISLATIVE ACTION Senate . House . . . . . ————————————————————————————————————————————————————————————————— ————————————————————————————————————————————————————————————————— The Committee on Appropriations (Gibson) recommended the following: 1 Senate Amendment (with title amendment) 2 3 Delete lines 28 - 69 4 and insert: 5 (b) “Health care provider” means a physician or physician 6 assistant licensed under chapter 458 or chapter 459 or an 7 advanced practice registered nurse registered under chapter 464. 8 (c) “Uterine fibroid” means a noncancerous growth of the 9 uterus that often appears during a woman’s childbearing years. 10 (2) UTERINE FIBROID RESEARCH DATABASE.— 11 (a) The department shall develop and maintain an electronic 12 database consisting of information related to uterine fibroids. 13 The purpose of the database is to encourage research relating to 14 the diagnosis and treatment of uterine fibroids and to ensure 15 that women are provided with the relevant information and health 16 care necessary to prevent and treat uterine fibroids. The 17 database must include, but need not be limited to, all of the 18 following information: 19 1. Incidence and prevalence of women diagnosed with uterine 20 fibroids in this state. 21 2. Demographic attributes of women diagnosed with uterine 22 fibroids in this state. 23 3. Treatments and procedures for uterine fibroids used by 24 health care providers in this state. 25 (b) A health care provider who diagnoses or treats a woman 26 with uterine fibroids shall submit information relating to such 27 diagnosis or treatment to the department in a form and manner 28 prescribed by department rule for inclusion in the database. 29 Such information may be submitted along with any reports or 30 other information that the health care provider is required to 31 submit to the department pursuant to state law. 32 (c) The database may not include any personal identifying 33 information of women diagnosed with or treated for uterine 34 fibroids. 35 (3) UTERINE FIBROID EDUCATION OUTREACH AND PUBLIC 36 AWARENESS.—The department shall develop and include information 37 related to uterine fibroids in its women’s health care 38 educational materials currently made available to the public. 39 The information must include, but need not be limited to, the 40 following: 41 (a) Possible risk factors for developing uterine fibroids. 42 (b) Range of available treatment options that are 43 considered alternatives to hysterectomy. 44 Section 2. For the 2022-2023 fiscal year, the sums of 45 $121,852 in recurring funds and $681,048 in nonrecurring funds 46 from the General Revenue Fund are appropriated to the Department 47 of Health and one full-time equivalent position with associated 48 salary rate of 55,212 is authorized for the purpose of 49 implementing this act. 50 51 ================= T I T L E A M E N D M E N T ================ 52 And the title is amended as follows: 53 Delete lines 12 - 18 54 and insert: 55 identifying information; requiring the department to 56 develop and include information related to uterine 57 fibroids in certain literature currently made 58 available to the public for a specified purpose; 59 providing an appropriation and authorizing a position; 60 providing an effective date.